Shares of several sports betting companies dropped Monday after lawmakers in Illinois passed a state budget that includes a new tax on the industry.

Nvidia is a significant investor in CoreWeave, and also sells the cloud company a lot of chips.

Tesla Inc.'s new-vehicle registrations fell further in France, undercutting Chief Executive Officer Elon Musk's assertion last month that the carmaker has recovered from its early-year sales slump. Bloomberg's Craig Trudell reports.

Lululemon Athletica Inc (NASDAQ:LULU) stock was last seen trading at $319.20, brushing off global trade tensions thanks to a price-target hike from TD Cowen to $373 from $370.

Sezzle is a high-growth BNPL pure-play, outpacing industry GMV growth and benefiting from rising consumer demand for flexible payments amid economic uncertainty. The exclusive WebBank partnership streamlines fees, reduces regulatory burden, and boosts monetization, supporting margin expansion and product innovation. The company's Q1 2025 results show surging revenue, expanding margins, and improved cost efficiency, prompting a 50% net income guidance raise for 2025.

OPEC+ will boost production by 411,000 bpd in July.

Sandisk Corporation posted a sequential revenue decline and a large GAAP loss due to a goodwill impairment, but beat non-GAAP EPS estimates. Gross margins deteriorated sharply, and oversupply is pressuring prices, but management expects gradual margin and profitability recovery next quarter. SanDisk's long-term outlook is tied to SSD adoption; the company must weather current downturns and maintain profitability until SSDs gain enterprise traction.

Tariffs have not yet impacted PayPal, or at least they have not shown themselves in the numbers. The company is aggressively repurchasing stock, using all earnings for buybacks, and maintains a strong net cash balance sheet. I expect growth rates to increase next year as the company completes its efforts to focus on profitable growth.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=151324&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq.

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) announced today new data from cohort B2 of the Phase 1/2 RAINFOL™-01 trial evaluating rinatabart sesutecan (Rina-S®), an investigational folate receptor alpha (FRα)-targeted, TOPO1-inhibitor antibody-drug conjugate (ADC). The study showed that with a median on-study follow-up of 7.7 months, treatment with Rina-S 100 mg/m2 every 3 weeks (Q3W) resulted in a 50.0 percent confirmed objective response rate (ORR), including two complete.

Media Release COPENHAGEN, Denmark; June 2, 2025 New data showed that rinatabart sesutecan (Rina-S ® ) 100 mg/m 2 led to a confirmed objective response rate (ORR) of 50.0 percent, including two complete responses (CR), and median duration of response (mDOR) was not reached after a median follow-up of 7.7 months Continued evaluation of single-agent Rina-S 100 mg/m 2 in patients with advanced endometrial cancer (EC) is ongoing in the Phase 2 RAINFOL™-01 trial and will be further evaluated in a planned Phase 3 trial Genmab A/S (Nasdaq: GMAB ) announced today new data from cohort B2 of the Phase …

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151326&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151325&wire=1&utm_campaign=7 or contact Joseph E.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amerant Bancorp Inc. (“Amerant” or the “Company”) (NYSE: AMTB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Landstar System, Inc. (“Landstar” or the “Company”) (NASDAQ: LSTR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Bill Stone, Glenview Trust Company chief investment officer, joins 'The Exchange' to discuss the tariff trade, opportunities in economic downturns and the pharma sector.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Senti Biosciences, Inc. (“Senti” or the “Company”) (NASDAQ: SNTI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

In 2023, Disney cut 7,000 jobs as part of an effort to save $5.5 billion in costs.

Casino stock Wynn Resorts Inc (NASDAQ:WYNN) is trading 1.9% lower at $88.83 at last check, starting off June on a sour note.

On the latest episode of After Earnings, we spoke with Lyft CEO David Risher about designing Lyft Silver for older adults who have been left out of the rideshare boom, how the company is turning its app into a $100 million advertising platform, and what it will take to balance a future of autonomous vehicles with the human touch that keeps rides personal.